251 related articles for article (PubMed ID: 31294380)
1. The Impact of Inflammatory Bowel Disease in Canada 2018: A Scientific Report from the Canadian Gastro-Intestinal Epidemiology Consortium to Crohn's and Colitis Canada.
Benchimol EI; Bernstein CN; Bitton A; Murthy SK; Nguyen GC; Lee K; Cooke-Lauder J; Siddiq S; Windsor JW; Carroll MW; Coward S; El-Matary W; Griffiths AM; Jones JL; Kuenzig ME; Lee L; Mack DR; Mawani M; Otley AR; Singh H; Targownik LE; Weizman AV; Kaplan GG
J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S1-S5. PubMed ID: 31294380
[TBL] [Abstract][Full Text] [Related]
2. The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services Utilization.
Kuenzig ME; Benchimol EI; Lee L; Targownik LE; Singh H; Kaplan GG; Bernstein CN; Bitton A; Nguyen GC; Lee K; Cooke-Lauder J; Murthy SK
J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S17-S33. PubMed ID: 31294382
[TBL] [Abstract][Full Text] [Related]
3. The Impact of Inflammatory Bowel Disease in Canada 2018: Children and Adolescents with IBD.
Carroll MW; Kuenzig ME; Mack DR; Otley AR; Griffiths AM; Kaplan GG; Bernstein CN; Bitton A; Murthy SK; Nguyen GC; Lee K; Cooke-Lauder J; Benchimol EI
J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S49-S67. PubMed ID: 31294385
[TBL] [Abstract][Full Text] [Related]
4. The Impact of Inflammatory Bowel Disease in Canada 2018: Epidemiology.
Kaplan GG; Bernstein CN; Coward S; Bitton A; Murthy SK; Nguyen GC; Lee K; Cooke-Lauder J; Benchimol EI
J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S6-S16. PubMed ID: 31294381
[TBL] [Abstract][Full Text] [Related]
5. Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Executive Summary.
Ellen Kuenzig M; Windsor JW; Barrett L; Bernstein CN; Bitton A; Carroll MW; Chauhan U; Coward S; Fowler S; Ghia JE; Geist R; Gibson DL; Graff LA; Griffiths AM; Guoxian Huang J; Jones JL; Khanna R; Lakatos PL; Lee K; Mack DR; Marshall JK; Mukhtar MS; Murthy SK; Nguyen GC; Panaccione R; Seow CH; Singh H; Tandon P; Targownik LE; Zelinsky S; Benchimol EI; Kaplan GG
J Can Assoc Gastroenterol; 2021 Dec; 4(Suppl 2):S1-S9. PubMed ID: 34755033
[TBL] [Abstract][Full Text] [Related]
6. The Impact of Inflammatory Bowel Disease in Canada 2018: IBD in Seniors.
Nguyen GC; Targownik LE; Singh H; Benchimol EI; Bitton A; Murthy SK; Bernstein CN; Lee K; Cooke-Lauder J; Kaplan GG
J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S68-S72. PubMed ID: 31294386
[TBL] [Abstract][Full Text] [Related]
7. The Impact of Inflammatory Bowel Disease in Canada 2018: IBD Research Landscape in Canada.
Rose KL; Sherman PM; Cooke-Lauder J; Mawani M; Benchimol EI; Kaplan GG; Bernstein CN; Bitton A; Murthy SK; Nguyen GC; Lee K
J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S81-S91. PubMed ID: 31294388
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory bowel disease: a Canadian burden of illness review.
Rocchi A; Benchimol EI; Bernstein CN; Bitton A; Feagan B; Panaccione R; Glasgow KW; Fernandes A; Ghosh S
Can J Gastroenterol; 2012 Nov; 26(11):811-7. PubMed ID: 23166905
[TBL] [Abstract][Full Text] [Related]
9. The Impact of Inflammatory Bowel Disease in Canada 2018: Quality of Life.
Jones JL; Nguyen GC; Benchimol EI; Bernstein CN; Bitton A; Kaplan GG; Murthy SK; Lee K; Cooke-Lauder J; Otley AR
J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S42-S48. PubMed ID: 31294384
[TBL] [Abstract][Full Text] [Related]
10. A national survey on the patterns of treatment of inflammatory bowel disease in Canada.
Hilsden RJ; Verhoef MJ; Best A; Pocobelli G
BMC Gastroenterol; 2003 Jun; 3():10. PubMed ID: 12791168
[TBL] [Abstract][Full Text] [Related]
11. The Challenges of Living with Inflammatory Bowel Disease: Summary of a Summit on Patient and Healthcare Provider Perspectives.
Bray J; Fernandes A; Nguyen GC; Otley AR; Heatherington J; Stretton J; Bollegala N; Benchimol EI
Can J Gastroenterol Hepatol; 2016; 2016():9430942. PubMed ID: 27446878
[TBL] [Abstract][Full Text] [Related]
12. Health-care costs of inflammatory bowel disease in a pan-European, community-based, inception cohort during 5 years of follow-up: a population-based study.
Burisch J; Vardi H; Schwartz D; Friger M; Kiudelis G; Kupčinskas J; Fumery M; Gower-Rousseau C; Lakatos L; Lakatos PL; D'Incà R; Sartini A; Valpiani D; Giannotta M; Arebi N; Duricova D; Bortlik M; Chetcuti Zammit S; Ellul P; Pedersen N; Kjeldsen J; Midjord JMM; Nielsen KR; Winther Andersen K; Andersen V; Katsanos KH; Christodoulou DK; Domislovic V; Krznaric Z; Sebastian S; Oksanen P; Collin P; Barros L; Magro F; Salupere R; Kievit HAL; Goldis A; Kaimakliotis IP; Dahlerup JF; Eriksson C; Halfvarson J; Fernandez A; Hernandez V; Turcan S; Belousova E; Langholz E; Munkholm P; Odes S;
Lancet Gastroenterol Hepatol; 2020 May; 5(5):454-464. PubMed ID: 32061322
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of inflammatory bowel disease in an insured population in Puerto Rico during 1996.
Torres EA; De Jesús R; Pérez CM; Iñesta M; Torres D; Morell C; Just E
P R Health Sci J; 2003 Sep; 22(3):253-8. PubMed ID: 14619451
[TBL] [Abstract][Full Text] [Related]
14. Familial occurrence and inheritance studies in inflammatory bowel disease.
Binder V; Orholm M
Neth J Med; 1996 Feb; 48(2):53-6. PubMed ID: 8819799
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory bowel disease register: Steps towards Crohn's & colitis foundation of Saudi Arabia (CCFSA).
Masoodi I; Alsayari K; Albishri J
Int J Health Sci (Qassim); 2012 Jun; 6(2):232-6. PubMed ID: 23580900
[TBL] [Abstract][Full Text] [Related]
16. Crohn's and Colitis Canada's 2021 Impact of COVID-19 & Inflammatory Bowel Disease in Canada: A Knowledge Translation Strategy.
Kaplan GG; Windsor JW; Crain J; Barrett L; Bernstein CN; Bitton A; Chauhan U; Coward S; Fowler S; Ghia JE; Gibson DL; Griffiths AM; Jones JL; Khanna R; Kuenzig ME; Lakatos PL; Lee K; Mack DR; Marshall JK; Mawani M; Murthy SK; Panaccione R; Seow CH; Targownik LE; Zelinsky S; Benchimol EI
J Can Assoc Gastroenterol; 2021 Dec; 4(Suppl 2):S10-S19. PubMed ID: 34755034
[TBL] [Abstract][Full Text] [Related]
17. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
[TBL] [Abstract][Full Text] [Related]
18. Direct hospital costs for patients with inflammatory bowel disease in a Canadian tertiary care university hospital.
Bernstein CN; Papineau N; Zajaczkowski J; Rawsthorne P; Okrusko G; Blanchard JF
Am J Gastroenterol; 2000 Mar; 95(3):677-83. PubMed ID: 10710056
[TBL] [Abstract][Full Text] [Related]
19. Crohn's disease and ulcerative colitis: morbidity and mortality.
Rod Riley
Health Rep; 1990; 2(4):343-59. PubMed ID: 2101290
[TBL] [Abstract][Full Text] [Related]
20. Impact of the World Inflammatory Bowel Disease Day and Crohn's and Colitis Awareness Week on Population Interest Between 2016 and 2020: Google Trends Analysis.
Silangcruz K; Nishimura Y; Czech T; Kimura N; Hagiya H; Koyama T; Otsuka F
JMIR Infodemiology; 2021; 1(1):e32856. PubMed ID: 37114197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
